Synergistic bactericidal activity of a novel dual β-lactam combination against methicillin-resistant Staphylococcus aureus
Journal of Antimicrobial Chemotherapy · 01.07.2024 · 79 (7) · 1677-1682
DOI: 10.1093/jac/dkae165 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 04.06.2024. Verfasst von Hala Altarawneh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manc…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Drug Synergism, Anti-Bacterial Agents, Staphylococcal Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Mutah, Ministry of Education, Fudan University.
Abstract (Originalsprache)
Objectives
MRSA is a major cause of hospital-acquired and community-acquired infections. Treatment options for MRSA are limited because of the rapid development of β-lactam resistance. Combining antibiotics offers an affordable, time-saving, viable and efficient approach for developing novel antimicrobial therapies. Both amoxicillin and cefdinir are oral β-lactams with indications for a wide range of bacterial infections and mild side effects. This study aimed to investigate the in vitro and in vivo efficacy of combining these two β-lactams against MRSA strains.
Methods
Fourteen representative prevalent MRSA strains with diverse sequence types (STs) were tested with a combination of amoxicillin and cefdinir, using chequerboard and time–kill assays. The Galleria mellonella larvae infection model was used to evaluate the in vivo efficacy of this dual combination against the community-acquired MRSA (CA-MRSA) strain USA300 and the hospital-acquired MRSA (HA-MRSA) strain COL.
Results
The chequerboard assay revealed a synergistic activity of the dual amoxicillin/cefdinir combination against all tested MRSA strains, with fractional inhibitory concentration index (FICI) values below 0.5 and at least a 4-fold reduction in the MICs of both antibiotics. Time–kill assays demonstrated synergistic bactericidal activity of this dual combination against the MRSA strain USA300 and strain COL. Moreover, in vivo studies showed that the administration of amoxicillin/cefdinir combination to G. mellonella larvae infected with MRSA strains significantly improved the survival rate up to 82%, which was comparable to the efficacy of vancomycin.
Conclusions
In vitro and in vivo studies indicate that the dual combination of amoxicillin/cefdinir demonstrates a synergistic bactericidal efficacy against MRSA strains of various STs. Further research is needed to explore its potential as a treatment option for MRSA infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, UK.
ORCID-Profile: Guoqing Xia
Förderung
- University of Mutah
- Ministry of Education
- Fudan University
Zitieren
APA
Altarawneh, H., Alhomra, T., Alharbi, M., Fan, Y., Derrick, J. P., & Xia, G. (2024). Synergistic bactericidal activity of a novel dual β-lactam combination against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 79(7), 1677-1682. https://doi.org/10.1093/jac/dkae165
Vancouver
Altarawneh H, Alhomra T, Alharbi M, Fan Y, Derrick JP, Xia G. Synergistic bactericidal activity of a novel dual β-lactam combination against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 2024;79(7):1677-1682. doi:10.1093/jac/dkae165
BibTeX
@article{Altarawneh2024,
author = {Altarawneh, Hala and Alhomra, Turki and Alharbi, Mohanned and Fan, Yaxin and Derrick, Jeremy P and Xia, Guoqing},
title = {Synergistic bactericidal activity of a novel dual β-lactam combination against methicillin-resistant Staphylococcus aureus},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
volume = {79},
number = {7},
pages = {1677--1682},
doi = {10.1093/jac/dkae165}
}
EUVIMED